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ABSTRACT  In the accompanying paper (Griffiths, G.,  P. Quinn, and G. Warren,  1983, J.  Cell 
Biol., 96: 835-850), we suggested that the Golgi stack could be divided into functionally distinct 
cis,  medial,  and  trans  compartments, each comprising one or two adjacent cisternae. These 
compartments were  identified using Baby  hamster kidney (BHK)  cells infected with Semliki 
Forest virus (SFV) and treated with monensin. This drug blocked intracellular transport but not 
synthesis of  the  viral  membrane  proteins  that  were  shown  to  accumulate  in  the  medial 
cisternae.  In  consequence,  these  cisternae  bound  nucleocapsids.  Here  we  show  that  this 
binding markedly  increased the density of the  medial  cisternae and  allowed  us to  separate 
them  from  cis  and  trans  Golgi cisternae. A  number of criteria were  used to  show that the 
intracellular capsid-binding membranes  (ICBMs)  observed  in  vivo were  the  same  as  those 
membranes sedimenting to a higher density in sucrose gradients in vitro, and this separation 
of  cisternae was  then  used  to  investigate the distribution, within the  Golgi  stack,  of  some 
specific Golgi functions. After labeling for 2.5 min with  [3H]palmitate, most of the fatty acid 
attached  to  viral  membrane  proteins  was  found  in  the  ICBM  fraction.  Because  the  viral 
membrane proteins appear to move from  cis to trans, this suggests that fatty acylation occurs 
in  the  cis  or  medial  Golgi  cisternae.  In  contrast,  the distribution of  ~l_2-mannosidase, an 
enzyme involved in  trimming  high-mannose oligosaccharides, and  of galactosyl transferase, 
which  is  involved  in  the  construction  of  complex  oligosaccharides, was  not  affected  by 
monensin treatment. Together with data in the accompanying paper, this would restrict these 
two  Golgi  functions to  the  trans  cisternae. Our data  strongly support the view  that  Golgi 
functions have specific and discrete locations within the Golgi stack. 
Understanding of the functions of the Golgi complex would be 
greatly facilitated if the component parts of the organeUe could 
be resolved. There have been many attempts to do this,  using 
the variations in the density (6),  surface properties  (15),  and 
antigenicity (17) of Golgi membranes. In contrast to cytochem- 
ical results,  which show sharp delimitations  of activities (see 
references 2, 7,  12), these procedures have, at best, produced 
subfractions enriched in certain Golgi activities, with consid- 
erable  amounts of these same activities being found in other 
fractions.  Lack of information about the localization of any 
Golgi marker enzymes has made it  impossible  to determine 
whether the observed distributions of activity result from cross- 
contamination of the subfractions or reflect the distribution of 
these  activities  between  different  compartments  which  have 
been separated (1, 3). 
One way to overcome this problem would be to perturb the 
physical properties of one specific part of the Golgi complex. 
This approach, using ethanol intoxication, has been tried with 
limited  success  (6,  9).  If the perturbation  were  sufficient  to 
cause a large change in the behavior of that particular subset 
of the Golgi membranes,  it should be possible to measure a 
number of Golgi complex functions and ask whether or not 
they follow  the  change  in  behavior.  Evidence  for activities 
clearly following, or not following, the change would strongly 
suggest specific locations within the Golgi complex for those 
functions.  Conversely,  an  activity  partially  following  the 
change would suggest that it is spread over at least two com- 
partments. 
In the preceding paper (13), we were able to identify the site, 
within  the  Golgi  complex,  at  which  monensin  blocked  the 
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This was possible because, although monensin blocked trans- 
port of these proteins, it did not prevent their synthesis.  In 
consequence, they accumulated in the compartment before the 
block, and there bound viral nucleocapsids. These intracellular 
capsid-binding membranes (ICBMs) were morphologically  dis- 
tinct from other Golgi cisteruae. Their origin was determined 
using a  variety of biochemical and cytochemical techniques, 
and they were shown to be derived from one or two cisternae 
from the middle of the stack which we termed medial cisternae. 
We were thus able to defme three distinct compartments, cis, 
medial and trans, each comprising one or two adjacent cisternae 
in the Golgi stack (13). 
Viral  nucleocapsids are  very  dense  (19)  and  membranes 
binding them in large numbers, a property possessed uniquely 
by medial cisternae in monensin-treated,  SFV-infected cells, 
should therefore have altered physical properties. They should, 
for example, have a higher equilibrium density than the other 
cisternal membranes. If  such a difference were to allow discrim- 
ination of the two membrane populations, it would be possible 
to investigate the distribution between them of Golgi functions. 
Here we show that in SFV-infected cells treated with monensin 
such a discrimination between Golgi compartments is possible 
and can be used to localize functions within the Golgi stack. 
MATERIALS  AND  METHODS 
These were all as previously described (10), with the additions or modifications 
that follow. 
Cell Fractionation:  Confluent Baby hamster kidney BHK cells on 10- 
cm dishes were scraped with a rubber policeman into ice-cold phosphate-buffered 
saline (PBS), and all subsequent operations performed at 4°C. They were washed 
three times by centrifugation (1,000 g, 5 rain) and resuspension in PBS. After the 
fmal wash, the cells were suspended in >10 vols of 10 mM Tris-HCI, pH 8.0, 1 
mM  MgC12, and collected by centrifugation (1,000 g,  l0 min).  The  pellet  of 
swollen cells was suspended in  l  vol of the same buffer containing 40 pg/ml 
phenylmethylsulphonyl fluoride (PMSF), and the cells were disrupted with  10 
strokes of an all-glass Dounce homogenizer. The homogenate was immediately 
adjusted to 250 mM sucrose, 20 mM PIPES, pH 7.0, 5 mM KCI, l mM MgC12 by 
addition of a  2x  stock solution.  Posmuclear supernatants were  prepared by 
centrifugation (600 g,  5  rain)  and layered over continuous sucrose gradients 
prepared from 6 ml each of 500 mM and 2 M sucrose solutions, both containing 
10 mM PIPES, pH 7.0, 5 mM KCI, 1 mM MgCI~. Gradients were centrifuged at 
30,000 rpm for 16 h  (Beckman SW40; Beckman Instruments, Inc., Spinco Div., 
Palo Alto, CA) and fractions were collected from the bottom of the tube. 
tabelingwith[aH]PalmiticAcid:  [aH]Palmitic  acid  (20 Ci/mmol, 
New England Nuclear, W. Germany) was lyophilized and redissolved in ethanol. 
10-cm dishes of confluent BHK cells were labeled 6 h after infection. They were 
washed twice with prewarmed PBS and then incubated at 37°C for 2.5 min with 
5  ml  of prewarmed  medium  containing 0.5  mCi/ml  [aH]palmitic acid.  For 
monensin-treated cells, the culture medium was adjusted to l0 pM monensin 2- 
h postinfection. This concentration of monensin was maintained in all subsequent 
incubation media. 
Quantitation  of  Radioactive  Virus  on  Polyacrylamide 
Gels:  [aH]palmitic acid is rapidly incorporated into cellular pbospholipid, 
giving a  high background to assays for labeling of protein. To overcome this, 
protein  was  collected  from  sucrose  gradient  fractions by  precipitation  with 
trichloroacetic acid in the presence of 100 pg of gelatin carrier. The precipitates 
were washed with ethanol and ether, dissolved in sample buffer (10), and resolved 
by  SDS  PAGE  to  separate  viral proteins  from  other  labeled  species.  After 
staining, individual gel tracks were excised with a scalpel and frozen on dry ice. 
Each track was cut into 2-Am slices which were dissolved in 0.5 ml of 9% (wt/ 
vol) H202, 10 mM HC1 by incubation at 60°C for 48 h, and counted in  10 ml 
Rotizint 22 (Ruth GmbH, Karlsruhe, W. Germany). Radioactivity in the viral 
protein was determined by comparison with [~S]methionine-labeled virus and 
molecular-weight markers run in parallel tracks. Immunoblotting was performed 
by the method of Burnette (4), modified as described previously (12). 
Assay  of  a~_2-Mannosidase  Activity:  This  was performed as 
described by Tabas  and Kornfeld (27),  except that the  [aH]mannose-labeled 
glycopeptides for use as substrate were prepared from SFV-infected BHK cells 
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treated with monensin to prevent oligosaccharide processing (13). Labeling with 
[~H]mannose, harvesting of the cells, proteolysis and purification of the glycopep- 
tides were done as described (10), except that the final chromatographic step on 
Biogel P4 was performed using water as the eluent. The high-mannose glycopep- 
tides were collected, lyophilized, and redissolved to 106 cpm/ml in 50 mM sodium 
phosphate, pH 6.5, 5 mM MgC12, 0.1% (wt/vol) Triton X-100 for use in the assay. 
As the mannosidase assay demands small volumes, some concentration of the 
gradient fractions was needed to obtain measurable activities. Since mannosidase 
is a  membrane protein (27) it was selectively extracted into Triton X-114 (2). 
This resulted in a 20-fold increase in concentration of both galactosyl transferase 
and mannosidase with no loss of activity and made it possible to use almost all 
of the gradient fractions for the assays. 
Morphomet?ic Estimation of the Volume Density of ICBMs 
in Fractions from the Sucrose Gradient:  The fractions  from the 
sucrose gradient were adjusted to 0.25 M sucrose and the membranes collected 
by centrifugation (100,0130 g, 60 rain). The pellets were suspended in 1% glutar- 
aldehyde in  100 mM  PIPES (pH 7.0) and left at 20°C for 30 rain. The fixed 
membranes were collected by microcentrifugation.  Further processing for electron 
microscopy was as described previously (12). Three blocks from each pellet were 
randomly sectioned. Fifteen micrographs  were taken for each fraction at the first 
grid corners where tissue was seen, at a primary magnification of x  7,000, and 
enlarged photographically to give a final magnification of x  23,000. All clearly 
recognizable ICBM  structures were marked and a  transparent square  lattice 
overlay (with 0.5-cm squares) was placed over each micrograph (28). All corner 
points (P) which covered ICBMs were counted and related to the total number 
of points over the micrograph. The ratio P~C8M/PToTAL  gives the volume density 
of ICBMs in each fraction. 
RESULTS 
ICBMS Are Denser than Normal Golgi Cisternae 
SFV-infected  ceils  were  labeled  with  [3H]mannose  for  10 
min  in  the  presence  or  absence  of  monensin.  Under  these 
conditions, only viral membrane proteins were labeled (Fig.  1) 
and [aH]mannose incorporated into protein could therefore be 
used to assay the viral membrane proteins. The cells were then 
incubated for 30 min in unlabeled media to allow transport of 
the tritiated viral proteins to the Golgi complex (10). Cells were 
harvested and postnuclear supernatants centrifuged to equilib- 
rium through continuous  sucrose gradients.  These were frac- 
tionated and assayed for [aH]mannose incorporated into pro- 
tein. The results showed that the Golgi membranes containing 
the viral proteins in monensin-treated  cells equilibrated  at  a 
higher density than those from the untreated cells (Fig. 2). 
These higher density membranes containing viral membrane 
proteins obtained  from monensin-treated cells were shown to 
be the ICBMs seen in vivo by the following biochemical and 
morphological criteria. 
EQUILIBRIUM  DENSITY  OF  THE  HIGH  DENSITY  MEMBRANE 
FRACTION  COULD  BE  LOWERED  BY  CONDITIONS  THAT  SPECIFI- 
CALLY  REMOVED  NUCLEOCAPSIDS"  ICBMs would be expected 
to have a higher density than normal Golgi membranes because 
of the  dense  nucleocapsids  bound  to  the  accumulated  viral 
membrane proteins. Removal of the capsids should therefore 
lower the equilibrium density of the membranes. Infected cells 
were labeled with [3H]mannose in the presence of monensin, 
incubated  in unlabeled  medium for 30 min, and fractionated 
on sucrose gradients. The fractions containing the labeled viral 
protein were pooled and the membranes collected by centrif- 
ugation after dilution of the sucrose to 0.25 M. The pellet was 
suspended  in 0.25  M  buffered  sucrose  and  divided  into  two 
portions.  One  portion,  with no further treatment, was re-run 
on  a  density  gradient  identical  to  that  used  in  the  original 
preparation. The other was adjusted to 100 mM NaC1, 50 mM 
Tris-HCI (pH 8.0), and refractionated on a gradient prepared 
in  this  buffer.  These  latter conditions  are  known  to  disrupt 
specifically the interaction between the nucleocapsids and the FIGURe  1  SDS  PAGE 
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FIGURE  2  Density gradient fractionation of SFV-infected BHK cells. 
The  cells  were  labeled  for  15  min  with  [aH]mannose  and  then 
incubated with  excess unlabeled mannose for 30 min.  Postnuclear 
supernatants were fractionated on linear sucrose gradients, and the 
fractions  assayed  for  [3H]mannose  labeled  protein.  Monensin- 
treated cells (O) were treated with  10 #M monensin from a 10 mM 
stock  in  ethanol  3  h  before  labeling,  and  this  concentration  of 
monensin was maintained in all subsequent incubation media until 
the cells  were  harvested. Control  cells  (O)  were  treated with  the 
same volume of ethanol without monensin at the same times. 
viral spike proteins  (14).  Fractions were  collected from  the 
gradients and assayed for viral protein. Collection and centrif- 
ugation of the membranes per se had no effect on their equi- 
librium density.  The  treatment  that  removed  nucleocapsids, 
however,  caused  the  membranes  to  re-equilibrate  at  a  lower 
density, not significantly  different  from that  of normal Golgi 
membranes (Fig. 3; cf. Fig. 2). 
MORPHOLOGY  OF  THE  HIGH  DENSITY  MEMBRANE  FRAC- 
TION:  A  preparation of infected BHK cells treated with mo- 
nensin was fractionated and the membranes enriched in spike 
proteins were collected, fixed, and prepared for electron mi- 
croscopy. Fig. 4  is a  low magnification field from an  Epon- 
embedded sample. By comparison with Fig. 5 which shows the 
appearance  of ICBMs  in  vivo,  it  is  clear  that  the  fraction 
contained many profiles easily identifiable as ICBMs (arrows) 
by the nucleocapsids bound  to the cytoplasmic face and the 
virus particles budded into the lumen. Only dearly identifiable 
ICBM structures are indicated. There are also significant num- 
bers of vacuoles which  we believe are ICBM  structures that 
have been damaged during the fractionation. 
MORPHOMETRY:  To  confirm that the  distribution of mor- 
phologically recognizable ICBMs across the gradient was the 
same as that found for labeled viral membrane  proteins, we 
fractionated  infected  BHK  cells  treated  with  monensin  on 
sucrose gradients. Each fractionation was prepared for electron 
microscopy and the volume densities of ICBMs in each were 
determined by morphometric analysis. An approximation of 
the  relative pellet volumes was obtained by measurement of 
total protein. The product of the two values thus reflects the 
relative numbers of ICBMs in each fraction. The results showed 
an  excellent  correlation  between  the  distribution  of clearly 
recognizable ICBMs and that of labeled viral protein (Fig. 6). 
We  concluded,  therefore,  that  the  high  density membranes 
containing  viral  membrane  proteins,  found  in  monensin- 
treated SFV-infected BHK cells, were the ICBMs observed in 
the intact cells. 
Localization  of Golgi Functions 
Since the density of the ICBM fraction, which derives from 
the medial cisternae of the Golgi complex stack, is greater than 
that of normal Golgi cisternae, at least two parts of the Golgi 
complex stack can be discriminated in vitro and activities thus 
assigned to locations within the stack of Golgi cisternae. 
FATTY ACID ADDITION:  The kinetics of fatty acid addition 
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FIGURE  3  Membranes containing  [aH]mannose-iabeled viral  pro- 
tein prepared from monensin treated cells refractionated on sucrose 
gradients.  Samples  were  re-run  under  conditions  permitting  the 
interaction  between  viral  membrane  proteins  and  nucleocapsids 
(O) or under conditions known to disrupt this interaction (O). 
QUINN  Eqr AI.  Dissection  of the Golg/Complex  853 FIGURES 4 and 5  Fig. 4: A  section through a pellet of the high density membrane fraction obtained from monensin-treated, SFV- 
infected cells. The arrows indicate ICBM structures which are identical to those seen in vivo (cf.  Fig. 5). The arrowheads indicate 
structures which may be ICBMs from which the nucleocapsids have been lost during fractionation. M,  Mitochondria. Bar, 0.5/Lm. 
x  23,000.  Fig. 5:  Part of the perinuclear cytoplasm of a  BHK cell  infected  with  SFV and  treated with  10 #M  monensin, showing 
typical ICBM structures  (arrows). Most of these have nucleocapsids  (C)  on their cytoplasmic surface and budded virions on the 
luminal side (V).  Bar, 0.4/~m. x  50,000. 
occurs at about the same time as the proteins are being trans- 
ferred  to  the  Golgi  complex,  and  may  therefore  occur  in 
transitional elements or cis Golgi cisternae (26). At present this 
activity cannot be assayed in vitro, and it was therefore inves- 
tigated by the  use of short time-period incorporation of ~H- 
labeled palmitic acid into viral proteins in vivo. Infected cells, 
preincubated with or without monensin, were labeled for 2.5 
min with [3H]palmitic acid and then fractionated. Protein from 
each  fraction was  collected and  run  on  polyacrylamide gels 
which were then sliced and assayed for 3H label. The radioac- 
tivity in viral protein in each fraction is shown in Fig. 7. Even 
after  only  2.5  min,  most  of the  palmitic acid-labeled viral 
protein was found in the ICBM fraction. 
GALACTOSYL  TRANSFERASE:  The biochemical function first 
attributed to the Golgi complex was transfer of terminal sugars 
to the trimmed oligosaccharide of newly synthesized proteins 
(8, 20). The enzymes involved, especially  galactosyl  transferase, 
have been widely used as biochemical markers for the Golgi 
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complex during isolation. 
Infected cells were labeled with [3H]mannose in the presence 
or absence of monensin. Postnuclear supernatants were centri- 
fuged  on  sucrose  gradients and  the  fractions obtained were 
assayed for 3H-labeled protein and galactosyl transferase activ- 
ity. The results showed that in the absence of monensin, viral 
protein and galactosyl transferase distributed through the gra- 
dient in the same manner (Fig. 8 a). After monensin treatment, 
the membranes containing the most labeled viral protein equil- 
ibrated at a  higher density, while the density of those mem- 
branes containing galactosyl transferase was unchanged (Fig. 
8 b). Clearly, the ICBMs can be distinguished from that part of 
the Golgi stack containing galactosyl transferase activity. This 
strongly suggests that at least this terminal transferase activity 
is absent from the medial Golgi membranes. 
Ctl_2-MANNOSIDASE  ACTIVITY:  Trimming of the core sugars 
found  on  newly synthesized proteins must  occur  before the 
proteins can accept sugars from the terminal transferases (see -o-~  5, 
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Density  gradient  distribution  of  ICBMs.  Cells  were 
treated for 4  h with  10 #M  monensin,  labeled and fractionated as 
described for Fig. 2.  Fractions were assayed for all-labeled protein 
(O). Membranes from each fraction were collected by centrifugation 
after  dilution  of  the  sucrose  to 0.25  M,  fixed, and  examined  by 
electron microscopy. The volume density of ICBMs in each fraction 
was determined. Total protein in each fraction was measured as an 
estimate of pellet volume. The product of these gives, in  arbitrary 
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FIGURE  7  Density gra- 
dient  fractionation  of 
I  cells labeled for 2.5 min  /  , 
with  [aH]palmitic  acid. 
~  Monensin  treated  cells 
,  Io/were  incubated for 
/  4 h with 10 ,aM monen- 
/  /  ',  ;  ~--.--  sin  before  labeling. 
~-=_~'~"~,  , V  -~-~-c.=~ 
2  16  12  08  04  Control  cells  (O)  re- 
Sucrose c0ncenfroti0n  (M)  ceived  an  equal 
amount of ethanol without  monensin.  Protein was collected from 
the gradient fractions and run on polyacrylamide gels. These were 
sliced and assayed for aH radioactivity in viral protein. 
reference 16). It has therefore been suggested that the trimming 
enzymes,  including the  ch_~-mannosidase, are localized in  a 
compartment of the Golgi complex separate from the terminal 
transferases, and earlier on the transport pathway (24). Infected 
cells, preincubated with or without monensin, were fractionated 
on  sucrose gradients. Membrane proteins were  concentrated 
from each fraction by phase separation into Triton X-114, and 
assayed for galactosyl transferase and a~_~-mannosidase activ- 
ities. The results showed no separation of the two activities, 
whether or not the cells were pretreated with monensin (Fig. 
9). 
Labeling with [aH]mannose would have interfered with the 
mannosidase assay and it was therefore necessary to confirm 
in  some  other  way  that  the  monensin  treatment  had  been 
effective in causing the viral glycoproteins from treated cells to 
equilibrate at a higher density than those from untreated cells. 
Samples from  each  gradient fraction were  therefore  run  on 
polyacrylamide gels  and  then  immunoblotted  (4),  and  the 
amount  of the  viral  glycoprotein  E1  in  each  fraction  was 
estimated. The density of the fraction containing the most E 1 
is marked with an arrow (Fig. 9). 
DISCUSSION 
We have subfractionated the Oolgi stack of cisternae by ex- 
ploiting the effect of monensin on SFV-infected BHK cells. By 
causing  the  medial  cisteruae  to  bind  nucleocapsids,  we  in- 
creased their density, allowing them to be discriminated from 
other cisternae in the stack. Using a variety of criteria, we have 
shown that the membranes sedimenting to higher density are 
identical to the ICBMs observed in vivo. Conditions known to 
disrupt the interaction between nucleocapsids and viral spike 
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FIGURE  8  Distribution of galactosyl transferase activity. Cells were 
labeled with  [aH]mannose as described in  Fig. 2 and fractionated 
on  sucrose  gradients.  Fractions  were assayed  for  [aH]mannose-la- 
beled protein tO) and galactosyl transferase  activity (O). (A) Control 
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FIGURE  9  Distribution  of  ~1_2-mannosidase  activity.  Cells  were 
fractionated  on  sucrose  gradients without  (A)  and  with  (B)  4  h 
pretreatment with monensin. Membrane proteins from each fraction 
were concentrated by partitioning into Triton X-114 and assayed for 
galactosyl transferase  (O)  and oh-2 mannosidase (0)  activities. The 
arrows mark the fractions containing the highest concentration of 
1:1, determined by immunoblotting (4). 
QUINN  ET  AL  Dissection of the Golgi Complex  855 membranes from untreated cells. Capsid-binding is thus both 
necessary and sufficient to explain the density changes and is 
consistent  with  changing  the  properties of only  the  medial 
cisternae, which alone bound significant numbers of nucleo- 
capsids (13). 
Addition of fatty acids to newly synthesized proteins is an 
earlier event  than  construction  of complex oligosaccharides 
(26)  and  occurs in the presence of monensin (18).  We have 
shown that monensin blocks transport from the medial to the 
trans cisternae (13);  and fatty acid addition should therefore 
occur  either  before  or  when  the  proteins  reach  the  medial 
cisternae. In this paper we have shown  that  after a  2.5-min. 
pulse with [~H]palmitic acid most of the tritiated viral protein 
is found in the medial compartment. This suggests that fatty 
acid addition occurs either in this compartment or in the cis 
compartment, followed by rapid transfer of the protein to the 
medial compartment. 
Though all the evidence in the previous paper suggested that 
monensin blocked transport from medial to trans cisternae (131, 
we were unable to excluce the possibility that monensin was 
having effects other than inhibition of transport. Inhibition of 
an enzyme involved at an early step in oligosaccharide proc- 
essing would invalidate the use of the stage reached in that 
processing as a  marker for the point reached in the transport 
pathway.  If this occurred, the ICBMs could have originated 
from the fusion of post-Golgi vesicles as oligosaccharide proc- 
essing is not required for transport (11, 23). Previous work (10) 
has  shown  that  the  viral  proteins  take  10-15  min  to  pass 
through the Golgi stack of four to six cisternae. Since fatty acid 
addition  is  an  earlier  event  than  construction  of complex 
oligosaccharides, and since viral proteins labeled with a  2.5- 
min pulse of palmitic acid are found mostly in ICBMs, it is 
reasonable to conclude that the ICBMs must be derived from 
a medial rather than a post-Golgi compartment. 
Both galactosyl transferase and al_2-mannosidase activities 
were  unaffected  by  monensin  treatment.  This  suggests  that 
they are both absent from the medial cisternae. Since ICBMs 
in vivo contain viral proteins beating only simple oligosaccha- 
rides (131, it is reasonable to conclude that  the enzymes in- 
volved in trimming and complex oligosaccharide construction 
are restricted to the trans cisternae. This is in agreement with 
recent work by Ruth  and  Berger (22)  on  the localization of 
galactosyl transferase but at first sight disagrees with work (5, 
21) showing a separation on sucrose density gradients of trim- 
ming enzyme (mannosidase) and terminal transferase (galac- 
tosyl transferase) activities. These authors have concluded that 
mannosidase activity is localized in cis Golgi cisternae on the 
basis of such  a  separation and  the  fact  that  trimming is an 
earlier biochemical event than complex oligosaccharide con- 
struction (16).  However, no immunocytochemical evidence for 
a cis location was presented. While both activities appear to be 
localized in the trans compartment as defined by the monensin 
block, it seems likely that they are in distinct compartments 
which  can  be resolved under  some circumstances. We have 
simply not been able to show such a separation in our system. 
The  use  of monensin  to  induce  a  change  in density of a 
subcompartment of the Golgi complex of SFV-infected cells is 
both limited in site of action and complicated by possible side 
effects. It is possible, however, that the same principle could be 
applied in other ways to different compartments of the intra- 
cellular transport pathway. An example would be the use of 
temperature-sensitive virus mutants, some of which have pro- 
teins  that  are  not  transported  beyond  specific points  when 
shifted to the nonpermissive temperature. The viral membrane 
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proteins therefore accumulate in a specific compartment of the 
transport pathway,  and  may then,  or when  returned  to  the 
permissive temperature, bind viral nucleocapsids (25).  These 
mutants should not only be free of ill-defined side effects, but 
offer the potential for perturbing other specific compartments 
of the transport pathway. 
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